Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant and PD-1 in liver metastasis colorectal cancer
NCT06999252Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Jul 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimegepant in colorectal cancer (CRC), sponsored by Fudan University. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
rimegepant
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06999252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999252.